- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor inflammation-associated neurotoxicity
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 29, Issue 4, Pages 803-810
Publisher
Springer Science and Business Media LLC
Online
2023-04-07
DOI
10.1038/s41591-023-02276-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in Immunotherapies for Gliomas
- (2022) Michael Zhang et al. Current Neurology and Neuroscience Reports
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
- (2022) Matthew J. Frigault et al. BLOOD
- The future of cancer immunotherapy for brain tumors: a collaborative workshop
- (2022) Christine E. Brown et al. Journal of Translational Medicine
- Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
- (2022) Jaime Gállego Pérez-Larraya et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
- (2021) Giulia Agliardi et al. Nature Communications
- Current Immunotherapies for Glioblastoma Multiforme
- (2021) Boyuan Huang et al. Frontiers in Immunology
- Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
- (2021) Brandon Douglas Brown et al. Frontiers in Oncology
- Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
- (2021) Nicholas A. Vitanza et al. NATURE MEDICINE
- CD19 directed CAR T cell therapy for treatment of primary CNS lymphoma
- (2021) Tanya Siddiqi et al. Blood Advances
- A review of glioblastoma immunotherapy
- (2020) Ravi Medikonda et al. JOURNAL OF NEURO-ONCOLOGY
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
- (2020) Johanna Theruvath et al. NATURE MEDICINE
- Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
- (2020) Laura K. Donovan et al. NATURE MEDICINE
- CAR T Cell Therapy for Pediatric Brain Tumors
- (2020) John D. Patterson et al. Frontiers in Oncology
- Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma
- (2020) Paolo Strati et al. Blood Advances
- AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review
- (2020) Michael Dougan et al. GASTROENTEROLOGY
- Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
- (2020) Elizabeth L. Siegler et al. Frontiers in Immunology
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
- (2020) Marcela V Maus et al. Journal for ImmunoTherapy of Cancer
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Neurotoxicity associated with cancer immunotherapy
- (2019) Claire Perrinjaquet et al. CURRENT OPINION IN NEUROLOGY
- Tisagenlecleucel CAR-T Cell Therapy in Secondary CNS Lymphoma
- (2019) Matthew J. Frigault et al. BLOOD
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy
- (2018) Haneen Shalabi et al. JOURNAL OF IMMUNOTHERAPY
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma
- (2014) Hongsheng Miao et al. PLoS One
- High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
- (2014) Janice P Dutcher et al. Journal for ImmunoTherapy of Cancer
- Immune modulation of learning, memory, neural plasticity and neurogenesis
- (2010) Raz Yirmiya et al. BRAIN BEHAVIOR AND IMMUNITY
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
- (2008) Dieta Brandsma et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started